<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Arisawa T</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>CpG island aberrant methylation is shown to be an important mechanism in gene silencing. The important role of IL-17 in inflammatory response to H. pylori colonization has been indicated. We investigated the influence of IL17A polymorphisms, -197 G > A (rs2275913) and *1249 C > T (rs3748067), on the methylation of DAPK and CDH1.&lt;h4>Methods&lt;/h4>Gastric mucosal samples were obtained from 401 subjects without malignancies. Methylation status of gene was determined by MSP. The genotyping of IL17A was performed by PCR-SSCP.&lt;h4>Results&lt;/h4>Methylations of DAPK and CDH1 were seen in 196 and 149 of all 401 subjects, respectively. Overall, *1249 T carrier was associated with a decreased risk for DAPK methylation, whereas -197 G > A was not. In the subjects older than 60 years old</pubmed_abstract><journal>BMC medical genetics</journal><pagination>59</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3458965</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa.</pubmed_title><pmcid>PMC3458965</pmcid><pubmed_authors>Arisawa T</pubmed_authors><pubmed_authors>Shibata T</pubmed_authors><pubmed_authors>Tahara T</pubmed_authors><pubmed_authors>Tsutsumi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa.</name><description>&lt;h4>Background&lt;/h4>CpG island aberrant methylation is shown to be an important mechanism in gene silencing. The important role of IL-17 in inflammatory response to H. pylori colonization has been indicated. We investigated the influence of IL17A polymorphisms, -197 G > A (rs2275913) and *1249 C > T (rs3748067), on the methylation of DAPK and CDH1.&lt;h4>Methods&lt;/h4>Gastric mucosal samples were obtained from 401 subjects without malignancies. Methylation status of gene was determined by MSP. The genotyping of IL17A was performed by PCR-SSCP.&lt;h4>Results&lt;/h4>Methylations of DAPK and CDH1 were seen in 196 and 149 of all 401 subjects, respectively. Overall, *1249 T carrier was associated with a decreased risk for DAPK methylation, whereas -197 G > A was not. In the subjects older than 60 years old</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jul</publication><modification>2025-04-04T03:44:49.22Z</modification><creation>2019-06-05T17:41:28Z</creation></dates><accession>S-EPMC3458965</accession><cross_references><pubmed>22827846</pubmed><doi>10.1186/1471-2350-13-59</doi></cross_references></HashMap>